Endometrial Hyperplasia

DBCOND0001317

Endometrial Hyperplasia is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
endometiral hyperplasia
Indicated drugs

Resolves to

Vocabularies
MeSHM0007412ICD-10N85.0SNOMED CT198321009MedDRA10001238UMLSC0010673

What you can answer from here — as of October 31, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
60Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Contraindicated drugsDrugs whose labels contraindicate them in this condition
Sign in
12Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Endometrial Hyperplasia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In